INTRODUCTION
Ubiquitination is a covalent modification of various cellular proteins. This post-translational modification is involved in various physiological processes, the best understood of which is the ubiquitin-dependent degradative pathway (Finley and Chau, 1991) . In this case, multiply ubiquitinated proteins are targeted for degradation. In addition, stable monoubiquitin adducts are found intracellularly, such as those involving nuclear histones and cytoplasmic arthrin and the cytoplasmic domain of receptors for platelet-derived growth factor and growth hormone (Yarden et al., 1986; Ball et al., 1987; Leung et al., 1987; Bonner et al., 1988) .
The first step in the ubiquitin-conjugation system is the activation of ubiquitin to a high-energy intermediate. This reaction is catalysed by El, the ubiquitin-activating enzyme (Ciechanover et al., 1982) . The two-step reaction involves the formation of a ubiquitin adenylate intermediate and the transfer of ubiquitin to a thiol site (Haas and Rose, 1982) . The ubiquitin is then transferred to one of the ubiquitin-carrier proteins (E2s) to generate a similar thiol ester linkage (Pickart and Rose, 1985) . At this point, ubiquitin can either be linked directly to a target protein or conjugated to proteins destined for degradation via the ubiquitin-protein ligases (E3s) Hershko, 1992) . Thus El provides the initial activated form of ubiquitin necessary for any conjugation reaction to occur. In this capacity, El plays a key regulatory role in any process affected by ubiquitin modification.
We (Handley et al., 1991) and others (Hatfield et al., 1990; Zachsenhaus and Scheinen, 1990; McGrath et al., 1991) have cloned and sequenced the cDNA for El from human, yeast and wheat. A single ubiquitous El mRNA of 3.5 kb predicts a cytoskeletal and has a perinuclear distribution. During G2-phase, El reappears in the nucleus before breakdown of the nuclear envelope. In mitotic cells, El localizes to both the mitotic spindle and the cytosol, but is absent from the chromosomes. Immunoblot analysis reveals multiple forms of El in HeLa whole cell extract. This heterogeneity is not a result of polyubiquitination and may represent inactive pools of El. Only the characteristic El doublet is able to activate ubiquitin. Cellfractionation studies reveal a differential distribution of specific El isoforms throughout the cell cycle. Therefore we propose that the subcellular localization of El may play a role in regulating cell-cycle-dependent conjugation of ubiquitin to target proteins. mature protein of -117 kDa. A new testis-specific gene, Sby, has also been cloned which shows extensive similarity to human El (Kay et al., 1991; Mitchell et al., 1991) . Sby has been proposed as a candidate for the spermatogenesis gene, Spy, which is required for the survival and proliferation of A spermatogonia during spermatogenesis (Burgoyne et al., 1986) . Indeed, ubiquitination of proteins and histones is thought to be involved in the marked changes in protein turnover, chromatin structure and cell-cell interactions that occur during spermatogenesis (Agell and Mezquita, 1988) .
The ubiquitin-mediated proteolytic system is known to play a key role in cell-cycle progression. Three mammalian cell lines have recently been described that appear to have a single temperature-sensitive defect in El. At the non-permissive temperature, AIS9, ts85 and ts2O cells are arrested at the S/G2-phase transition (Sheinin, 1976; Ciechanover et al., 1984; Finley et al., 1984; Kulka et al., 1988; Mayer et al., 1989) . As the removal of ubiquitin from histone 2A is a prerequisite for chromosome condensation, the role of El in these cell lines could be related to its ability to activate ubiquitin and thus permit its covalent attachment to histones 2A and 2B during interphase (Bonner et al., 1988) . Indeed, AlS9 cells lose the capacity to convert newly replicated small DNA strands into chromosomal DNA at the non-permissive temperature (Sheinin, 1976) .
Ubiquitin-mediated degradation is also essential for cell-cycle progression from metaphase. In this case, degradation of both cyclin A and cyclin B appear to be mediated by the ubiquitin system (Glotzer et al., 1991; Hershko et al., 1991) . The mechanisms whereby the mitotic cyclins are specifically degraded at metaphase are poorly understood. Both cyclin A and B are known to form complexes with the highly conserved phosphoserine/threonine kinase, p34cdc2. The cyclin B-cdc2 complex is thought to activate the cyclin destruction pathway presumably by phosphorylation/dephosphorylation of an unknown substrate, driving the cells into interphase of the next cell cycle (Luca et al., 1991) . Given that the timing of cyclin destruction is determined by the cell-cycle stage of the cytoplasm rather than the cell-cycle stage of the cyclins themselves (Luca et al., 1991) , possibly one or more of the components of the ubiquitin system are modified in such a way that degradation of a specific protein is initiated.
We have previously described the subcellular localization of ubiquitin-activating enzyme, El (Schwartz et al., 1992; Trausch et al., 1993) , and found its distribution within exponentially growing populations of cells to be variable, with some cells having positive nuclei and others negative nuclei (Trausch et al., 1993) . We consider it possible that the ubiquitin system may perform distinct essential roles by changing subcellular localization of El during the cell cycle. Indeed, in support of the notion of a proteolytic system within the nucleus, Tsuneoka and Mekada (1992) have demonstrated the rapid intranuclear degradation of an abnormal malfolded protein expressed transiently in COS cells. In this study we have used the IC5 anti-El monoclonal antibody in immunofluorescence and cell-fractionation techniques to address the possibility that the subcellular localization of El varies with the cell cycle. We demonstrate here that the appearance and localization of El isoforms is cell-cycledependent, and may be regulated by post-translational modifications.
MATERIALS AND METHODS Antibodies/labelling reagents lC5 is a mouse IgM monoclonal antibody raised against human El (Schwartz et al., 1992) . Affinity-purified goat anti-mouse IgM-rhodamine was from Chemicon and goat anti-mouse IgG-fluorescein was obtained from Boehringer. Rabbit polyclonal ubiquitin-conjugated antibodies have been described previously (Schwartz et al., 1987) . Rabbit anti-lamin (A,B,C) was a gift from L. Gerace (Scripps Clinic, La Jolla, CA, U.S.A.).
Synchronization procedures
Exponentially growing cells were arrested at various stages of the cell cycle as described by Pines and Hunter (1989) and Tobey et al. (1990) . To 
Immunofluorescence
Immunofluorescence experiments were conducted as described previously (Trausch et al., 1983 (1984, 1985) . Briefly, cells were lysed with ice-cold lysis buffer [5 mM sodium phosphate (pH 7.4), 50 mM NaCl, 150 mM sucrose, 5 mM KCI, 2 mM DTT, 1 mM MgCl2, 0.5 mM CaCl2, 0.1 mM PMSF and 0.01 % digitonin). Nuclei were then collected from lysed cells on a cushion of a mixture of 300% sucrose, 2.5 mM Tris/HCl, pH 7.4, and 10 mM NaCl, after centrifugation at 1000 g for 10 min at 4 'C. Nuclei were subsequently extracted twice in Nonidet P40 buffer (0.5 % Nonidet P40, 10 mM sodium phosphate buffer, pH 7.4, 120 mM NaCl, 0.1 mM PMSF) for 30 min on ice. The nuclei were then collected by centrifugation (1000 g for 10 min at 4 0C) and boiled on a Coulter Elite FAC scan. For example, in asynchronous for IO min at I IO 'C in Laemmli reducing sample buffer (Laemmli, 1970) . Characterization of the cytoplasmic and nucleoplasmic fractions was performed in two ways. Quantitative immunoblots were evaluated for ,?-tubulin, which was present at more than 95 % in the cytoplasmic fraction. In addition, lactate dehydrogenase activity was assayed in all fractions; less than 1.6 % was detected in the nuclear fraction.
Immunoblot Samples were diluted in Laemmli sample buffer, boiled for 10 min at 110°C, and fractionated by SDS/PAGE. The separated proteins were electrophoretically transferred to nitrocellulose paper at 10 'C. lC5 tissue culture supernatant was diluted to 1:10 in Tris-buffered saline (20 mM Tris/HCl, pH 7.5, 137 mM NaCl, 0.1 % Tween 20) and incubated with the blot at room temperature for 1 h. Bound antibody was subsequently detected with either '251-labelled goat anti-mouse IgM and autoradiography as described previously (Schwartz et al., 1986) or colorimetrically using diaminobenzidine tetrahydrochloride (Aldrich) and hydrogen peroxide.
Isolation of pH 9 eluate A crude preparation of El, E2s and E3s (i.e. pH 9 eluate) was prepared from rabbit reticulocytes by the affinity-chromatography procedure described by Ciechanover et al. (1982) .
Purffication of active El from HeLa whole cell extract
Active El was prepared from HeLa whole cell extract by the affinity-chromatography procedure described by Ciechanover et al. (1982) , with the following modification; fraction II was concentrated using an Amicon 30 kDa centriprep concentrator in place of (NH4)2SO4 precipitation.
Ubiquitin-conjugation assays Ubiquitin-conjugation assays were performed essentially as described (Mayer et al., 1989; Schwartz et al., 1992) . Briefly, the reaction mixture contained, in a final volume of 50 ul, 20 mM Tris/HCl, pH 7.6, 2 mM DTT, 5 mM MgCl2, 20 jug of ox RNAase, 1 ,uM 1251-ubiquitin and pH 9 eluate/crude cell extract/fraction II. In addition, the reaction mixtures were supplemented with either an ATP-regenerating system (+ATP lanes) (i.e. 500 uM ATP, 10 l,g of creatine kinase, 1O mM phosphocreatine or an ATP-depleting system (-ATP lanes) (i.e. 50 mM 2-deoxyglucose, 2.5 ,ug of hexokinase). After incubation at 37 'C for 30 min, the reaction was terminated by the addition of Laemmli sample buffer. Conjugates were resolved by SDS/PAGE (12.5 % acrylamide), and detected by autoradiography.
RESULTS
We have previously used immunofluorescent microscopy to determine the subcellular distribution of El in exponentially growing cells (Trausch et al., 1993) . Using monoclonal antibody IC5, we observed that the subcellular distribution of El varied within a given population of cells. In order to establish whether this was due to differential localization of El with the cell cycle, we used immunofluorescence with iC5 to assess the subcellular localization of El in HeLa cells arrested at various stages of the cell cycle. Figures I(a) -l(f) are arranged according to the welldefined stages of the cell cycle. Cells arrested in GO-phase display exclusively cytoplasmic staining of El, which appears to be cytoskeletal (Figure la) . In contrast, Gl-phase cells show both nuclear and cytosolic El (Figure lb) . The nuclear staining is diffuse and extranucleolar. The cytoplasmic staining, although still cytoskeletal, differs from that of resting cells and appears filamentous. The relative staining of El changes in cells arrested at the GI/S boundary by aphidicolin ( Figure Ic) ; the nuclear staining becoming less prominent. The cytoplasmic distribution ofE1 also alters, with El found in a more perinuclear distribution. Negative nuclei and perinuclear staining are also characteristics of S-phase cells (Figure ld) . During G2-phase, El was detected throughout the nucleus, except in the nucleoli (Figure le) , and the cytoplasmic staining was similar to that of late S-phase. Thus the subcellular distribution of El changes as a cell progresses through the cell cycle. Examination of exponentially growing HeLa cells revealed the presence of all the cellular staining described above (Figure 1f) , thus eliminating the possibility that the subcellular distribution of El described in Figures 1(a)-1(e) is an artifact of the treatments used to arrest the cells.
We next determined the distribution of El during M-phase. As a portion of El colocalizes with microtubules (Trausch et al., 1993) , we scanned exponentially growing populations of HeLa cells for mitotic cells rather than arresting the cells with microtubule-disrupting agents such as nocodazole or vinblastine. Figure 2 shows a composite of mitotic HeLa cells as observed by immunofluorescence using IC5 antibody. During prophase (Figure 2a) , El is diffusely distributed throughout the cell. During metaphase (Figures 2b and 2c) , El is localized on the mitotic spindle, but is excluded from the chromosomes. El is also uniformly distributed throughout the cytoplasm of the cell. As the cell progresses into anaphase (Figure 2d) , the El remains (Figures 2e and 2f) , which show the characteristic cleavage furrow, demonstrate El associated with the intracellular bridge. El remains associated with the intracellular bridge long after the two daughter cells have become nucleated (Figures 2e and 2f ). This pattern of immunofluorescent staining suggests that El is not associated with the bulk of chromatin, but is associated with the mitotic spindle throughout mitosis.
It has recently been shown that cyclin A is degraded before breakdown of the nuclear envelope (Minshull et al., 1990) . In order for El and the ubiquitin system to be instrumental in cyclin A degradation, El would have to enter the nucleus while the nuclear lamin is still intact. Alternatively, El could activate ubiquitin in the cytoplasm, and the activated ubiquitin bound to E2 could be transported into the nucleus. In order to distinguish between these two possibilities, we used double-label immunofluorescence to detect both El and nuclear lamin in cells arrested in the G2-phase. Figures 3(a) and 3(b) show that in G2-phase, El is localized in the nucleus of cells that have a bright nuclear lamin ring. This suggests that El is detectable in the nucleus before the breakdown of the nuclear envelope.
Thus these studies demonstrate the changes in the subcellular compartmentalization of El at various stages of the cell cycle. We next sought to determine whether post-translational modifications of El within a single compartment regulate the activity of this enzyme. Monoclonal antibody lC5 recognizes multiple forms of El by immunoblot analysis in a variety of cell lines (Trausch et al., 1993) . The cellular distribution of these isoforms, however, is unknown (Figures 1-3 Mayer et al., 1989) . In order to assess a possible contribution of the other El isoforms in ubiquitin activation, fraction II was prepared from HeLa whole cell extracts, and El purified by ubiquitin-affinity chromatography. Figure 5 clearly shows that whole cell extracts contain multiple species of El (lane 1), and that these forms of El bound to the ion-exchange column and were eluted as fraction II (lane 4). The ability of these forms to activate ubiquitin was subsequently tested by ubiquitin-affinity chromatography. When HeLa-cell fraction II was applied to the ubiquitin-Sepharose column [although more E1(I 12) than El(I 19)], a proportion of E1(112/119) bound to the ubiquitin-Sepharose column, consistent with previous studies , and was eluted by AMP/PP1 (lane 7), and DTT-containing buffer (lane 8). In contrast, E1(126)-E1 (1 50) proteins failed to bind to the affinity column, and were detected in the column flowthrough and wash fractions (lanes 5 and 6). This suggests that only El isoforms El(112) and El (119) present which of these species are identified in the formaldehydefixed cells. Future studies will be directed toward characterization of the biochemical differences in the individual species of El. As El is autoubiquitinated (Arnold and Gevers, 1990) , we considered it possible that some of the El isoforms may represent part of an El-ubiquitin 'ladder'. To test this hypothesis, we sought to establish whether El-ubiquitin conjugates could be generated by a system reconstituted in vitro. Both rabbit reticulocyte fraction II and a crude preparation of El, E2s and E3s (pH 9 eluate) supported ATP-dependent ubiquitin-conjugation (results not shown). The predominant high-molecularmass reaction product in pH 9 eluate was a single ubiquitinated protein, which appears to correspond to El(l 19) (Figure 6b , lane 5). Addition of purified El resulted in an increase in this monoubiquitinated species of El (Figure 6b, lane 7) . This did not represent the previously characterized El-s-ubiquitin, as all samples were subjected to boiling for 10 min at 110°C in Laemmli sample buffer containing 710 mM 2-mercaptoethanol, a treatment known to cleave the thiol-ester bond (Ciechanover et al., 1982) . Similar results were obtained when the experiment was conducted in the presence of rabbit reticulocyte fraction II (Figure 6a ). High-molecular-mass conjugates of El were not observed in either case (Figures 6a and 6b ). These results demonstrate that El is monoubiquitinated, but not polyubiquitinated.
We next determined the subcellular localization of all of the El isoforms at various stages of the cell cycle. Crude cytoplasmic and nuclear fractions were prepared from synchronized HeLa cells. The proteins contained within each fraction were separated by SDS/PAGE, transferred to nitrocellulose, and immunoblotted with lC5 antibodies. Furthermore, these cytosolic forms remained constant throughout the cell cycle (Figures 7a-7f, lanes 1) . During M-phase, most forms of El were located in the cytosol fraction ( Figure 7f , lane 1). The El isoforms detected within the nucleoplasm varied considerably according to the cell-cycle stage. In resting cells and during Gl-phase, the predominant forms in the nucleoplasm were El(l 19) and E1 (133) (Figures 7a and 7b, lane 2) . As the cells progressed from the GI/S boundary to G2, the El pattern Rabbit reticulocyte fraction 11 (a) or rabbit pH 9 eluate (b) was incubated with 1251-ubiquitin in the presence of an ATP-regenerating (+ATP) or depleting (-ATP) system as described in the Materials and methods section. The reaction mixtures were incubated for 15 min at 37°C and terminated by boiling in Laemmli sample buffer. Samples (lanes 1-4) were fractionated by SDS/PAGE (7.5% gels), transferred to nitrocellulose, and blofted with 1C5, and bound antibody was detected colorimetrically. Duplicate samples were fractionated by SDS/PAGE, and the 1251-ubiquitin conjugates subsequently detected by autoradiography (lanes 5-8). Molecular-mass markers are on the left in kDa. Arrow denotes the ubiquitinated El species. became more complex (Figures 7c-7e , lane 2). There were no forms of El present in the nucleoplasm fraction of M-phase cells as predicted (Figure 7f , lane 2). El isoforms were also found associated with the nuclear skeleton. E1(133) was identifiable at both the GI/S transition and during G2-M (Figure 7c , lane 3), whereas E1(126) was only present during G1/S (Figures 7e and  7f , lane 3). There were no detectable forms of El associated with the nuclear skeleton during GO-, Gi-or S-phase (Figures 7a, 7b and 7d, lanes 3). However, immunoblot analysis of cellular fractions suggests that El is predominantly cytoplasmic in both GO-and GI-phase, whereas immunofluorescence suggests that El is mainly cytoplasmic in GO, but nuclear in GI. It is possible that the epitope recognized by monoclonal antibody 1C5 changes in accessibility during the cell cycle or under different assay conditions. Future studies with epitope-tagged constructs should clarify this issue in the future. Nonetheless, taken together we conclude that both the number and subcellular localization of El isoforms are cell-cycle-dependent.
DISCUSSION
We have previously used immunoelectron and immunofluorescent microscopy to describe the subcellular localization of ubiquitin-activating enzyme, El (Schwartz et al., 1992; Trausch et al., 1993) . We identified both a nuclear pool of El, associated with the heterochromatin, and a cytoplasmic pool of El, associated with the endosomal/lysosomal membranes, rough endoplasmic reticulum and cytoskeleton. In the course of these studies, we noted that the subcellular localization of El within an exponentially growing population of cells varied. Given that ubiquitination of substrates such as histones and cyclins is cellcycle-dependent (Bonner et al., 1988; Glotzer et al., 1991) We have confirmed and extended previous observations regarding the heterogeneity of El Mayer et al., 1989; Vierstra 1989, 1993; Trausch et al., 1993) . We have identified about eight forms of El from HeLa cells, only two of which are able to activate ubiquitin as judged by the ability to bind to ubiquitin-Sepharose in an ATP-dependent manner. The nature and function of El heterogeneity are at present unknown. Multiple functions and/or forms have also been demonstrated for other components of the ubiquitin system, e.g. the ubiquitin-carrier proteins (E2s) as a result of multiple genes, each encoding an E2 with a distinct substrate specificity (Jentsch et al., 1990) . As El mutations are lethal in both yeast and mammalian cells Kulkla et al., 1988; Zachsenhaus and Scheinen, 1990; McGrath et al., 1991) , it is presumed that El is the product of a single gene. Indeed, a single gene encoding E1(1 12) has been isolated from yeast and human cells (Zachsenhaus and Scheinen, 1990; Handley et al., 1991; McGrath et al., 1991) , and maps to the X chromosome (Zachsenhaus and Scheinen, 1990) . However, the isolation of multiple El genes from wheat germ (Hatfield et al., 1990; Hatfield and Vierstra, 1993) , together with our observations that El isoforms are not freely interchangeable, raises the possibility that heterogeneity of mammalian Els may be the result of multiple genes. Indeed, a gene encoding an El homologue has recently been identified on the Y chromosome of mice (Kay et al., 1991; Mitchell et al., 1991) .
Alternatively, El heterogeneity may be a consequence of posttranslational modification(s) of a single gene product. The possibility that the higher-molecular-mass forms of El represent polyubiquitinated forms of E1(1 12) may be excluded. However, our data do support the hypothesis Arnold and Gevers, 1990 ) that El(I 19) is a monoubiquitinated form of El(I 12). Other monoubiquitin adducts are found intracellularly [e.g. nuclear histones (Bonner et al., 1988) ]. The physiological significance of monoubiquitinated adducts in general is not clear, although it is suggested that these species are not rapidly degraded (Finley and Chau, 1991) . Our finding that ubiquitinated El(l 19) is found predominantly in the nucleoplasm fraction of HeLa cells suggests that such a modification may be necessary for the functioning and/or retention of El within the nucleus and/or cytoskeleton.
Our observation that only the E1(1 12/119) 'doublet' is able to support ubiquitin-conjugating activity raises important questions with regard to the function of the other El isoforms. As both the appearance and subcellular localization of the inactive El isoforms change as a cell progresses through the cell cycle, it is tempting to speculate that El plays a role in cell-cycle control which is unrelated to ubiquitin-activation. El is essential for cellcycle progression, at both the S/G2 transition and M-phase. However, as transfection of the cDNA for a truncated form of E1(I 12) rescues the El mutation in AlS9 cells, and M-phase appears to be dependent on a ubiquitin-activating form of El (Zachsenhaus and Scheinen, 1990; Glotzer et al., 1991; Hershko et al., 1991) , the role that a non-ubiquitin-activating form of El may play is unclear at present. An alternative interpretation is that the high-molecular-mass species of El represent inactive forms of El(112/119). Post-translational modification(s), oligomer formation and/or interaction with inhibitor protein(s) are all possible mechanisms whereby El(112/119) could be rendered inactive. The conversion of an inactive form of El to a ubiquitin-conjugating form could represent an important mechanism whereby ubiquitin-mediated proteolysis is regulated.
Quantitative immunoblot analysis reveals that the cellular abundance of free ubiquitin and El(I 12) are approximately equal (Schwartz et al., 1987 (Schwartz et al., , 1992 . As microinjection studies have revealed that free ubiquitin is equally distributed between the cytosol and the nucleus , movement of El from one subcellular compartment to another may represent a mechanism whereby ubiquitin-conjugating activity is regulated. Indeed, ubiquitinmediated degradation of the plant photoreceptor, phytochrome, correlates with changes in subcellular localization of the substrate (McCurdy and Pratt, 1986; Jabben et al., 1989) . Thus subcellular localization of the components of the ubiquitin system may represent a common mechanism for regulating ubiquitinmediated proteolysis. The immunofluorescence and immunoblot evidence presented in this study suggests that both the subcellular localization and form of El are cell-cycle-dependent. Alternatively, the possibility exists that availability of the lC5 epitope varies with the stage of the cell cycle, as has been observed in other systems (e.g. Turner et al., 1985) . However, as discussed above, different assay systems (immunofluorescence, immunoblot of cellular fractions) with non-identical limitations were used in the present study. Future studies using epitopetagged El constructs will clarify these issues. As El is known to play a key role in cell-cycle regulation, it is possible that changes in its subcellular localization contribute towards the specific ubiquitination and/or degradation of substrates at precise phases of the cell cycle.
Studies on protein import into the nucleus have revealed that the information required for targeting is encoded in a short polybasic amino acid sequence (Dingwall and Laskey, 1991) .
Simian Virus (SV40) T-antigen. The seven-amino acid sequence -PKKKRKV-is both necessary and sufficient for its nuclear localization. Many nuclear targeting sequences are now thought to be more complex than that of the SV40 T-antigen, and a functional bipartite signal motif has been proposed as another consensus for nuclear targeting (Dingwall and Laskey, 1991) . Human El contains three polybasic -KKRR-, -SKKRRVand -SKRKLGR-sequences which resemble the nuclear targeting sequence of the SV40 T-antigen, but lack a bipartite signal motif (Zachsenhaus and Scheinen, 1990; Handley et al., 1991) . However, as the nature of El heterogeneity is uncertain, and as it is not known which form(s) of El are translocated to the nucleus, the mechanism(s) responsible for nuclear import of this enzyme have yet to be elucidated. Mutation analysis and transfection studies are currently underway in our laboratory to assess the contribution of the polybasic sequences in human El to nuclear translocation of this enzyme.
The present study provides a framework for further elucidation of the role of the ubiquitin system in the degradation of nuclear proteins during the cell cycle. The mechanisms for intranuclear protein degradation are poorly understood. Several nuclear proteins are rapidly degraded in vivo and also serve as substrates for the ubiquitin-mediated system in vitro . Furthermore, Ellison and Hochstrasser (1991) have suggested that the ubiquitin system is responsible for the degradation of the yeast nuclear a2 repressor. Most recently, Tsuneoka and Mekada (1992) have demonstrated the rapid intranuclear degradation of an abnormally folded nuclear-localized protein in transfected COS cells, presumably mediated by the ubiquitin system. Taken together these studies suggest a potential role for the ubiquitin system in the turnover of nuclear proteins.
